Skip to content

FINHUB Insights

EN

Sign in Sign up

Danaher

DHR Health Care Market cap $167B as of Oct 30, 2026 09:32 ET S&P 500

Q3 FY26 Jun 27 – Sep 25, 2026 reported Oct 21, 2026

Revenue$6.55B +8% year over year

Gross profit$3.84B 59% margin

Operating profit$1.25B 19% margin

Net profit$1.24B 19% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Sep 25, 2026).
Item	Value	Share of revenue	Year over year
Revenue	6.55	100%	+8%
North America	2.47	38%
High-growth markets	1.96	30%
Western Europe	1.54	24%
Other developed markets	0.29	4%
Other	0.29	4%
Cost of revenue	−2.72	41%
Gross profit	3.84	59% margin
R&D	−0.43	7%	+0pp
SG&A	−2.16	33%	+0pp
Operating profit	1.25	19% margin	+0pp
Interest & other costs	−0.09
Tax benefit	0.08
Net profit	1.24	19% margin	+4pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 26, 2026).
Item	Value	Share of revenue	Year over year
Revenue	6.27	100%	+6%
Recurring	5.20	83%	+5%
Nonrecurring	1.07	17%	+10%
Cost of revenue	−2.65	42%
Gross profit	3.61	58% margin	−2pp
R&D	−0.41	7%	+0pp
SG&A	−2.07	33%	−7pp
Operating profit	1.13	18% margin	+5pp
Interest & other costs	−0.05
Tax	−0.21
Net profit	0.87	14% margin	+5pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 27, 2026).
Item	Value	Share of revenue	Year over year
Revenue	5.95	100%	+4%
Recurring	5.03	85%	+4%
Nonrecurring	0.92	15%	−1%
Cost of revenue	−2.36	40%
Gross profit	3.59	60% margin	−1pp
R&D	−0.39	7%	+0pp
SG&A	−1.86	31%	−1pp
Operating profit	1.34	23% margin	+0pp
Interest & other costs	−0.11
Tax	−0.21
Net profit	1.03	17% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	6.84	100%	+5%
Recurring	5.32	78%	+4%
Nonrecurring	1.51	22%	+6%
Cost of revenue	−2.87	42%
Gross profit	3.97	58% margin	−1pp
R&D	−0.44	6%	+0pp
SG&A	−2.03	30%	−1pp
Operating profit	1.50	22% margin	+0pp
Interest & other costs	−0.12
Tax	−0.19
Net profit	1.20	18% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 26, 2025).
Item	Value	Share of revenue	Year over year
Revenue	6.05	100%	+4%
Recurring	5.02	83%	+5%
Nonrecurring	1.04	17%	+1%
Cost of revenue	−2.53	42%
Gross profit	3.52	58% margin	+0pp
R&D	−0.38	6%	+0pp
SG&A	−1.99	33%	−3pp
Operating profit	1.15	19% margin	+3pp
Interest & other costs	−0.08
Tax	−0.17
Net profit	0.91	15% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

The balance sheet, capital flow, debt schedule and capital structure open with a free account.

Quarter by quarter

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26 Jun 27 – Sep 25, 2026 reported Oct 21, 2026 Operating margin 19% Net profit $1.24B	Jun 27 – Sep 25, 2026	Oct 21, 2026	$6.6B	+8%	19%	$1.24B	19%
Q2 FY26 Mar 28 – Jun 26, 2026 reported Jul 21, 2026 Operating margin 18% Net profit $0.87B	Mar 28 – Jun 26, 2026	Jul 21, 2026	$6.3B	+6%	18%	$0.87B	14%
Q1 FY26 Jan 1 – Mar 27, 2026 reported Apr 21, 2026 Operating margin 23% Net profit $1.03B	Jan 1 – Mar 27, 2026	Apr 21, 2026	$6.0B	+4%	23%	$1.03B	17%
Q4 FY25 Sep 27 – Dec 31, 2025 reported Feb 24, 2026 Operating margin 22% Net profit $1.20B	Sep 27 – Dec 31, 2025	Feb 24, 2026	$6.8B	+5%	22%	$1.20B	18%
Q3 FY25 Jun 28 – Sep 26, 2025 reported Oct 21, 2025 Operating margin 19% Net profit $0.91B	Jun 28 – Sep 26, 2025	Oct 21, 2025	$6.1B	+4%	19%	$0.91B	15%